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Abstract
The aim of this study is to estimate the preva-
lence of HIV/HBV and HIV/HCV coinfections 
among AIDS cases reported in Brazil, and to de-
scribe the epidemiological profile of these cases. 
Coinfection was identified through probabilistic 
record linkage of the data of all patients carry-
ing the HIV virus recorded as AIDS patients and 
of those patients reported as carriers of hepatitis 
B or C virus in various databases from the Bra-
zilian Ministry of Health from 1999 to 2010. In 
this period 370,672 AIDS cases were reported, of 
which 3,724 were HIV/HBV coinfections. Women 
are less likely to become coinfected than men 
and the chance of coinfection increases with age. 
This study allowed an important evaluation of 
HBV/HIV and HCV/HIV coinfections in Brazil us-
ing information obtained via merging secondary 
databases from the Ministry of Health, without 
conducting seroprevalence research. The find-
ings of this study might be important for plan-
ning activities of the Brazilian epidemiologic 
surveillance agencies.
Hepatitis Viruses; HIV; Acquired  
Immunodeficiency Syndrome; Coinfection
Resumo
O presente estudo tem como objetivo estimar 
a prevalência de coinfecção HIV/HBV e HIV/
HCV entre os casos de AIDS notificados no Bra-
sil e descrever o perfil epidemiológico dos casos 
coinfectados. A coinfecção foi identificada pelo 
relacionamento probabilístico entre todos os pa-
cientes com HIV notificados como casos de AIDS, 
e os casos de hepatites virais B e C em diferentes 
bases de dados do Ministério da Saúde, no perí-
odo de 1999 a 2010. Nesse período, 370.672 casos 
de AIDS foram notificados, sendo 3.724 coinfec-
tados com HBV e 5.932 com HCV. As mulheres 
têm menos chance de coinfecção que os homens. 
A chance de coinfecção aumenta com a idade, 
sendo três vezes maior entre os coinfectados com 
HBV com 45 anos ou mais. Este estudo permitiu 
uma importante avaliação dos perfis de coinfec-
ção por HBV/HIV e HCV/HIV no Brasil pela uti-
lização de dados secundários do Ministério da 
Saúde. Os achados deste estudo podem ser úteis 
para planejar ações de vigilância epidemiológi-
ca no Brasil.
Vírus da Hepatite; HIV; Síndrome de  
Imunodeficiência Adquirida; Coinfecção
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Introduction
HIV infection has a pandemic aspect and is ex-
tremely severe, making it one of the most im-
portant current health problems 1,2,3. Hepatitis 
viruses cause liver infections of different types, 
depending on the etiologic agent, the most 
common being the type A (HAV), B (HBV), and 
C (HCV) viruses 2,4,5. The importance of viral 
hepatitis in public health is well known due to 
the large number of infected individuals and the 
complications caused by the infection 2.
Hepatitis B and C viruses and the HIV virus 
share the most important forms of transmission, 
in particular sexual, by blood, and vertical (moth-
er to child) transmission. Infections by these vi-
ruses present a dynamic interaction, amplifying 
each other and leading to greater morbidity and 
mortality in coinfected patients. HIV-infected in-
dividuals who also develop acute hepatitis B are 5 
to 6 times more likely to become chronic carriers 
of HBV and are also at greater risk of developing 
severe liver diseases that may result in death 6,7.
The HIV virus accelerates the evolution of 
liver diseases caused by hepatitis B and C, espe-
cially in patients with greater immune deficien-
cies. Thus, coinfected patients suffer more severe 
consequences than mono-infected patients. For 
example, HIV/HCV coinfected individuals show 
a faster progression of fibrosis, the risk of verti-
cal transmission increases from 6% to 20%, and 
the risk of sexual transmission increases by 3%. 
Among HIV/HBV coinfected individuals, the in-
fection is more severe and causes more aggres-
sive cases of cirrhosis and liver cancer. In this 
situation, the risk of cirrhosis increases 4.2-fold, 
mortality also increases, and, in some cases, the 
hepatitis B virus can be reactivated 8,9,10.
According to Soriano et al. 9, the prevalence 
of patients coinfected with HIV/AIDS and hep-
atitis B and C varies worldwide because of the 
different forms of transmission. Clinical studies 
conducted in Brazil show that, among HIV/AIDS-
infected individuals, about 6% were positive for 
HBsAg, while anti-HCV positivity varies from 5 
to 18% 9,10.
The main purpose of this study is to estimate 
the prevalence of HIV/HBV and HIV/HCV coin-
fections among notifiable AIDS cases in Brazil, as 
well as to describe the epidemiological profile of 
these cases.
Material and methods
This study examined the data of all HIV-positive 
patients who were reported as AIDS patients 
in Brazil and who met the criteria that define 
an AIDS case. Data was obtained from various 
sources, including the Notifiable Diseases Infor-
mation System (SINAN), the Laboratory Tests 
Control System (SISCEL), and Medication Logis-
tics Control System (SICLOM), which are data-
bases of the Brazilian Ministry of Health.
AIDS cases in children and adults from 1999 
to 2010 were obtained from the SINAN database. 
From the SISCEL and SICLOM databases, the pa-
tients’ records during the period of 2000 to 2010 
that met the following criteria were selected: (i) 
TCD4+ cell count less than expected for the age 
and detectable viral load; (ii) TCD4+ cell count 
less than expected for the age and use of medica-
tion registered in SICLOM; (iii) TCD4+ cell count 
less than expected for the age, detectable viral 
load, and use of medication 11.
Cases of viral hepatitis B and C were obtained 
from SINAN’s notifications for the period 1999 to 
2010. For hepatitis B, cases that presented at least 
one of the following serum markers were con-
sidered: HBsAg, Anti-HBc IgM, or HBeAg; and 
for hepatitis C, those with the following markers 
were considered: anti-HCV and HCV-RNA 2.
Linkage between AIDS and hepatitis B and 
C cases were used to estimate the prevalence of 
HIV/HBV and HIV/HCV coinfection.
The database initially contained 371,631 
AIDS cases between 1999 and 2010. 11 records 
that did not contain information about the city 
of residence, 901 records that did not contain the 
birth date, and 47 with inconsistent birth date 
were excluded, bringing the final total to 370,672 
AIDS cases (99.7%).
The variable “category of exposure” (related 
to AIDS) used in the analysis was extracted from 
the SINAN database. The categories “heterosexu-
al”, “homosexual”, and “bisexual” were regrouped 
under the category “sexual transmission”, while 
the categories “transfusion” and “hemophiliac” 
were regrouped under “blood transmission”.
A logistic regression model was used to esti-
mate the chance of patients being coinfected de-
pending on certain socio-demographic variables. 
The measure of association presented is the odds 
ratio (OR), with corresponding 95% confidence 
intervals (95%CI). Separate analyses were con-
ducted for HIV/HBV and HIV/HCV coinfections. 
Analyses were conducted using Stata v.12 soft-
ware (Stata Corp., College Station, USA).
Results
In Brazil, 370,672 AIDS cases were reported in the 
period of 1999 to 2010, 86.3% of which were reg-
istered in the SINAN database and 13.7% in the 
SISCEL and SICLOM databases. Globally, 50.7% 
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of these notifications came from the Southeast 
region, followed by the South (22.9%), Northeast 
(14.5%), Central (6.2%), and North (5.7%). AIDS 
patients are, on average, 43 years old (median = 
43 years), and 24.2% of them have 4 to 7 years 
of schooling. Most of these patients are male 
(61.0%), white (35.9%), and fall into the category 
of sexual exposure (64.9%).
Record linkages of the AIDS and viral hepa-
titis B and C databases allowed for detection of 
3,724 HIV/HBV-coinfected and 5,932 HIV/HCV-
coinfected individuals. Thus, we observed that 
1% and 1.6%, respectively, of the notifiable AIDS 
cases presented HBV/HIV and HCV/HIV coinfec-
tions during the period 1999 to 2010.
Table 1 shows that HIV/AIDS-infected in-
dividuals (coinfected and non-coinfected) are 
mostly males. It is also notable that 81.0% and 
73.7%, respectively, of HBV and HCV-coinfected 
individuals are male. Thus, women are less likely 
to become coinfected than men (HBV/HIV: OR = 
0.39, 95%CI: 0.35-0.42; HCV/HIV: OR = 0.78, 
95%CI: 0.73-0.83). The chance of coinfection in-
creases with age; it is three times higher in older 
individuals coinfected with HBV than patients 
aged 24 and younger; among those coinfected 
with HCV, the chance can be up to 12 times 
higher.
The geographical distribution of individu-
als coinfected with hepatitis B shows that the 
Southeast region has 57.1% of all notifiable cases, 
followed by the South (23.2%), and the Central 
(7.7%) regions (Figure 1). Among those coinfected 
with hepatitis C, the Southeast region has 65.9% 
of all notifiable cases, also followed by the South 
(28.5%), as showed in Figure 1. According to dis-
tribution by race/color, most patients are white: 
43.8% and 48.2%, respectively, of HBV and HCV 
coinfected individuals. With regard to schooling, 
most individuals coinfected with HBV have had 
at least 8 years of formal education (32.9%) and, 
among those coinfected with HCV, 34.6% have 
had 4-7 years (Table 1).
The logistic regression model shows that, 
in relation to schooling, patients with at least 8 
years of formal education are 26% more likely to 
have HIV/HBV coinfection when compared to 
patients with no schooling. Among the HIV/HCV 
coinfected patients, the chance of coinfection in-
creases with more years of schooling – up to twice 
as high (Table 1).
Most cases fell into the category of exposure 
to AIDS through sexual activity (homosexual, bi-
sexual, and heterosexual), followed by injecting 
drug users (IDU). The percentage of blood ex-
posure is below 1% for all coinfected individuals 
(Table 1). However, the chance for coinfections 
increases 2- to 6-fold for HBV and HCV, respec-
tively, when the IDU category is compared with 
sexual exposure.
Discussion
For this study, we used positive symptomatic 
cases of hepatitis B and C recorded in the SINAN 
database. It has been suggested that the number 
of viral hepatitis cases in the official databases 
are underestimated 6,7,12. Besides that, we under-
stand that the undernotification of viral hepatitis, 
which can also be related to limited access to se-
rologic diagnosis of HCV and HBV, may fluctuate 
Figure 1
Distribution of coinfected HIV/AIDS-HBV and HIV/AIDS-HCV cases, by region of residence. Brazil, 1999-2010.
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Table 1
Distribution of HIV/AIDS cases mono and coinfected with HBV and HCV, by socio-demographic variables. Brazil, 1999 to 2010.
Variables Not coinfected Coinfected with 
HBV
ORadjusted 95%CI Coinfected with HCV ORadjusted 95%CI
n % n % n %
Total 361,325 100.0 3,724 100.0 5,932 100.0
Age group (years)
< 25 17,202 4.8 33 0.9 1.00 16 0.2 1.00
25-34 62,149 17.2 595 16.0 2.91 1.94-4.34 318 5.4 3.45 1.90-6.28
35-44 124,675 34.5 1,413 37.9 3.11 2.09-4.63 2,290 38.6 9.80 5.43-17.68
45 or older 157,299 43.5 1,683 45.2 2.92 1.96-4.35 3,308 55.8 12.11 6.72-21.84
Gender
Male 219,118 60.6 3,018 81.0 1.00 4,369 73.7 1.00
Female 142,188 39.4 706 19.0 0.39 0.35-0.42 1,563 26.3 0.78 0.73-0.83
Unknown * 19 0.0 0 - 0 -
Race/Color
White 128,618 35.6 1,630 43.8 1.00 2,862 48.2 1.00
Black or mixed 104,193 28.8 1,093 29.4 0.99 0.91-1.08 1,345 22.7 0.89 0.84-0.96
Asian or indigenous Indian 1,522 0.4 11 0.3 0.60 0.33-1.09 22 0.4 0.81 0.53-1.24
Unknown * 126,992 35.1 990 26.6 0.79 0.72-0.86 1,703 28.7 0.86 0.81-0.92
Education (years)
None 10,238 2.8 85 2.3 1.00 92 1.6 1.00
1-3 48,873 13.5 483 13.0 1.01 0.80-1.28 950 16.0 1.58 1.27-1.96
4-7 86,783 24.0 1,026 27.6 1.16 0.93-1.45 2,055 34.6 2.08 1.68-2.57
8 or more 93,872 26.0 1,226 32.9 1.26 1.01-1.57 1,711 28.8 1.96 1.59-2.43
Unknown * 121,559 33.6 904 24.3 1.07 0.85-1.34 1,124 18.9 1.39 1.12-1.73
Category of transmission  
Sexual ** 235,546 65.2 2,453 65.9 1.00 2,914 49.1 1.00
IDU 23,478 6.5 579 15.5 1.79 1.62-1.96 2,259 38.1 6.37 6.00-6.77
Blood *** 389 0.1 8 0.2 1.63 0.81-3.29 33 0.6 6.59 4.58-9.48
Vertical transmission 8,338 2.3 11 0.3 0.41 0.21-0.80 9 0.2 0.86 0.39-1.90
Unknown * 93,574 25.9 673 18.1 0.74 0.67-0.82 717 12.1 0.78 0.72-0.86
HBV: hepatitis B virus; HCV: hepatitis C virus; IDU: injecting drug users. 
Source: Ministry of Health, Sanitary Surveillance Agency, Department of STDs, AIDS and Viral Hepatitis. 
* Not available in the datasets; 
** Sexual: homosexual, bisexual, and heterosexual; 
*** Blood: hemophiliac and transfusion.
between regions of Brazil. Therefore, compari-
sons of stratified data estimated by region might 
be problematic and biased.
A potential weakness of using information 
from official databases is related to its accuracy 
(misclassification) and potential under-notifica-
tion, which might introduce outcome misclas-
sification (coinfection identification), making 
estimates of measures of effect (for instance, 
odds ratios) prone to bias. However, there is no 
evidence that the linkage procedure or that the 
case under-notification processes are not equal 
according to exposure variables, such as gen-
der, age group, race, education and category of 
transmission, satisfying the criteria for the in-
terpretation of the results presented in Table 1. 
Nevertheless, this study permitted an important 
evaluation of HBV/HIV and HCV/HIV coinfec-
tions in Brazil using information obtained via 
merging secondary databases from the Brazilian 
Ministry of Health, without the need to conduct 
seroprevalence research. Furthermore, it allowed 
for a description of the epidemiologic profile of 
individuals coinfected with HBV/HIV and HVC/
HIV in recent years in Brazil, as well as the iden-
tification of potential risk factors associated with 
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these coinfections. In our study, coinfection 
prevalence is estimated considering all notifiable 
and available HIV cases from the Brazilian Min-
istry of Health’s official databases. In order to re-
duce probability of undernotification, we consid-
ered information from different sources (SINAN, 
SISCEL, SICLOM). It is also important to high-
light that notifiable HIV/AIDS cases in Brazil 
receive medicine for treatment free of charge, 
which may contribute to improved data quality.
Even though the estimates of coinfections 
may be underestimated, our study has corrobo-
rated many results from the literature 1,3,4,13. We 
observe that the prevalence of HIV/AIDS in the 
population is greater among men than women 
with approximately two infected men for every 
woman. Similar results were found in this study 
in relation to hepatitis B and C infections, helping 
to explain why more than 80% of coinfected in-
dividuals are male 1,3,4,13. The principal source of 
infection by hepatitis B and HIV is sexual, which 
is also observed in coinfected patients, especial-
ly men who have sex with men, a category that 
corresponds to 32% of all coinfections among 
males. The main form of hepatitis C transmis-
sion is contact with contaminated blood, and this 
mechanism is also one of the main forms of HIV 
transmission 4,7,8,10. This explains the significant 
presence of drug users among the coinfected in-
dividuals (38.1%).
The findings of this study might be useful for 
planning activities of the Brazilian epidemio-
logic surveillance agencies, as well as to guide 
prevalence and incidence studies to obtain more 
detailed data to improve understanding of the 
HBV/HIV and HCV/HIV coinfections.
Resumen
Estimar la prevalencia de las coinfecciones VIH/VHB y 
VIH/VHC entre los casos de SIDA notificados en Brasil 
y describir el perfil epidemiológico de las coinfecciones. 
Los casos de coinfección se identificaron por el método 
de conexión probabilística entre los pacientes con VIH 
notificados como SIDA y los casos de hepatitis B y C en 
los diversos sistemas de información del Ministerio de 
la Salud entre 1999 y 2010. Entre 1999 y 2010, 370.672 
casos de SIDA fueron notificados, estos 3724 coinfec-
tados con VHB y 5932 con VHC. Las mujeres son me-
nos propensas a ser co-infectadas que los hombres. La 
oportunidad de coinfección aumenta con la edad. Este 
estudio proporciona una evaluación importante de los 
perfiles de la coinfección por VIH/VHB y VHC/VIH en 
Brasil, a través de la utilización de datos secundarios 
del Ministerio de Salud. Este estudio sirve para orientar 
las acciones de vigilancia epidemiológica en Brasil, así 
como guiar estudios de prevalencia e incidencia que fo-
menten una mejor comprensión de la coinfección VIH/
VHB y VIH/VHC.
Virus de la Hepatitis; VIH; Síndrome de  
Inmunodeficiencia Adquirida; Coinfección
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